Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer

被引：1
|
作者：
Le Chevalier, T
Bérille, J
Zalcberg, JR
Millward, MJ
Monnier, A
Douillard, JY
McKeage, MJ
James, R
Soulas, F
Loret, C
Bougon, N
Bizzari, JP
机构：
[1] Inst Gustave Roussy, Dept Med, F-94805 Villejuif, France
[2] Rhone Poulenc Rorer, Antony, France
[3] Heidelberg Repatriat Hosp, Heidelberg, Vic, Australia
[4] Peter MacCallum Canc Inst, E Melbourne, Australia
[5] CHG A Boulloche, Montbeliard, France
[6] Prince Wales Hosp, Randwick, NSW 2031, Australia
[7] Rhone Poulenc Rorer, Melbourne, Vic, Australia
来源：
SEMINARS IN ONCOLOGY | 1999年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：13 / 18
页数：6
相关论文
共 50 条
  • [31] Docetaxel (D, Taxotere®) with concurrent radiation in locally advanced non-small cell lung cancer (NSCLC)
    Aamdal, S
    Hagen, I
    Avril, I
    Lauvvang, G
    Owre, K
    Hatlevoll, R
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S260 - S260
  • [32] Docetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancer
    Adjei, AA
    Argiris, A
    Murren, JR
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (05) : 32 - 40
  • [33] Combination Chemotherapy with Docetaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer
    W. Schuette
    I. Bork
    B. Wollschläger
    S. Schädlich
    [J]. Clinical Drug Investigation, 2001, 21 : 161 - 168
  • [34] Combination chemotherapy with docetaxel and carboplatin for advanced non-small cell lung cancer
    Schuette, W
    Bork, I
    Wollschläger, B
    Schädlich, S
    [J]. CLINICAL DRUG INVESTIGATION, 2001, 21 (03) : 161 - 168
  • [35] Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer
    Cascone, Tina
    Gold, Kathryn A.
    Swisher, Stephen G.
    Liu, Diane D.
    Fossella, Frank V.
    Sepesi, Boris
    Pataer, Apar
    Weissferdt, Annikka
    Kalhor, Neda
    Vaporciyan, Ara A.
    Hofstetter, Wayne L.
    Wistuba, Ignacio I.
    Heymach, John V.
    Kim, Edward S.
    William, William N., Jr.
    [J]. ANNALS OF THORACIC SURGERY, 2018, 105 (02): : 418 - 424
  • [36] Docetaxel (Taxotere®) in combination chemotherapy and in association with thoracic radiotherapy for the treatment of non-small-cell lung cancer
    Ornstein, DL
    Nervi, AM
    Rigas, JR
    [J]. ANNALS OF ONCOLOGY, 1999, 10 : 35 - 40
  • [37] Cisplatin, ifosfamide and vinorelbine combination in advanced non-small cell lung cancer
    Baron, FJ
    Cueva, JF
    Vazquez, F
    Candamio, S
    Calvo, M
    Sanz, A
    Irigoyen, A
    Menendez, MD
    Huidobro, C
    Lopez, R
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 99 - 99
  • [38] Docetaxel in non-small cell lung cancer: a review
    Davies, AM
    Lara, PN
    Mack, PC
    Gandara, DR
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (04) : 553 - 565
  • [39] The use of docetaxel in non-small cell lung cancer
    Bishop, JF
    Clarke, SJ
    [J]. UPDATES IN ADVANCES IN LUNG CANCER, 1997, 29 : 106 - 116
  • [40] Docetaxel in advanced non-small cell lung cancer
    Wakelee, H
    Ramalingam, S
    Belani, CP
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (01) : 13 - 24
12345